Lifecore Biomedical Inc (LFCR)

NASD · Healthcare · Drug Manufacturers - Specialty & Generic · USA

Lifecore Biomedical Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.

Lifecore Biomedical is a contract development and manufacturing organization specializing in aseptic filling of complex sterile injectable products in syringes, vials and cartridges. The company manufactures pharmaceutical-grade hyaluronic acid using a proprietary fermentation process and provides formulation development and analytical services across three cGMP facilities. Its customers include biopharmaceutical companies developing products for ophthalmic and orthopedic applications.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Lifecore Biomedical Inc stock.

Our verdict on LFCR

Not valued: We cannot value this company yet.

ETFs with the most weight in LFCR

14 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Drug Manufacturers - Specialty & Generic

All 82 Drug Manufacturers - Specialty & Generic stocks

Cheaper than LFCR in Drug Manufacturers - Specialty & Generic

33 more in this industry show a wider margin of safety.

Is LFCR undervalued or overvalued?

We do not publish a verdict on LFCR yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of LFCR?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.